Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M5GX
|
|||
| Former ID |
DIB015562
|
|||
| Drug Name |
Priorix
|
|||
| Synonyms |
GSK-209762; MMR vaccine, SB
Click to Show/Hide
|
|||
| Indication | Measles [ICD-11: 1F03] | Approved | [1], [2] | |
| Varicella zoster virus infection [ICD-11: 1E91] | Approved | [1] | ||
| Company |
GlaxoSmithKline Biologicals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT00388440) Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.